The Journal of Clinical Investigation (Mar 2022)

Single-cell analysis of somatic mutation burden in mammary epithelial cells of pathogenic BRCA1/2 mutation carriers

  • Shixiang Sun,
  • Kristina Brazhnik,
  • Moonsook Lee,
  • Alexander Y. Maslov,
  • Yi Zhang,
  • Zhenqiu Huang,
  • Susan Klugman,
  • Ben H. Park,
  • Jan Vijg,
  • Cristina Montagna

Journal volume & issue
Vol. 132, no. 5

Abstract

Read online

Inherited germline mutations in the breast cancer gene 1 (BRCA1) or BRCA2 genes (herein BRCA1/2) greatly increase the risk of breast and ovarian cancer, presumably by elevating somatic mutational errors as a consequence of deficient DNA repair. However, this has never been directly demonstrated by a comprehensive analysis of the somatic mutational landscape of primary, noncancer, mammary epithelial cells of women diagnosed with pathogenic BRCA1/2 germline mutations. Here, we used an accurate, single-cell whole-genome sequencing approach to first show that telomerized primary mammary epithelial cells heterozygous for a highly penetrant BRCA1 variant displayed a robustly elevated mutation frequency as compared with their isogenic control cells. We then demonstrated a small but statistically significant increase in mutation frequency in mammary epithelial cells isolated from the breast of BRCA1/2 mutation carriers as compared with those obtained from age-matched controls with no genetically increased risk for breast cancer.

Keywords